BioCentury
ARTICLE | Clinical News

MicOryx: Additional Phase I/IIa data

May 25, 2015 7:00 AM UTC

Oryx said 1 heavily pretreated patient with bulky metastases who received MicOryx in an open-label, German Phase I/IIa trial achieved stable disease. The trial enrolled 22 patients with advanced MSI-H...